TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35096742

Group type: EXPERIMENTAL
Intervention: Nomogram for cancer-specific survival (CSS) based on independent prognostic factors (age, race, T stage, histological grade, surgery, radiotherapy, chemotherapy)
Number of subjects: 1985

Group type: EXPERIMENTAL
Intervention: Nomogram for cancer-specific survival (CSS)
Number of subjects: 1985

Group type: EXPERIMENTAL
Intervention: Nomogram-related decision curve analysis (DCA)
Number of subjects: 1985

Group type: EXPERIMENTAL
Intervention: Risk stratification using nomogram
Number of subjects: 1985
Study: 36420360

Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy (SMT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham spinal manipulative therapy (sham SMT)
Number of subjects: 20
Study: 32045673

Group type: EXPERIMENTAL
Intervention: Indacaterol 150 μg with 9 g charcoal (charcoal-block condition)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Indacaterol 150 μg without charcoal (non-block condition)
Number of subjects: 72
Study: 35806853

Group type: EXPERIMENTAL
Intervention: High-Load Resistance Exercise (HL-RE) combined with Aerobic Exercise (AE)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Low-Load Resistance Exercise (LL-RE) combined with Aerobic Exercise (AE)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Aerobic Exercise (AE)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: High-Load Resistance Exercise (HL-RE)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Low-Load Resistance Exercise (LL-RE)
Number of subjects: 79
Study: 35187850

Group type: EXPERIMENTAL
Intervention: ABVE-PC
Number of subjects: 224

Group type: COMPARATOR
Intervention: ABVD
Number of subjects: 224
Study: 34536984

Group type: EXPERIMENTAL
Intervention: Higher agency scores
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Action component of agency
Number of subjects: 131
Study: 32708971

Group type: EXPERIMENTAL
Intervention: Bridging therapy with r-tPA (bolus, partial dose, or full dose)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Direct MTE
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Full r-tPA dose
Number of subjects: 103
Study: 36363493

Group type: EXPERIMENTAL
Intervention: Continuous cold flow (CCF) therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cold pack (gel ice)
Number of subjects: 100
Study: 35199220

Group type: EXPERIMENTAL
Intervention: POD3/2 CRP
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: BMI ≥ 25 kg/m2
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: POD3/2 CRP > 1
Number of subjects: 344
Study: 34116715

Group type: EXPERIMENTAL
Intervention: Low-dose IL-2 therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34940781

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus Bevacizumab
Number of subjects: 915

Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 915
Study: 34643353

Group type: EXPERIMENTAL
Intervention: Continuous supportive telephone counselling for 14 days after neonatal discharge
Number of subjects: 65

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 65
Study: 32446164

Group type: EXPERIMENTAL
Intervention: Antiepileptic drugs (AEDs) treatment including levetiracetam (LEV), valproic acid (VA), and carbamazepine.
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (healthy participants).
Number of subjects: 90
Study: 34688577

Group type: EXPERIMENTAL
Intervention: SLBs + FC
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: SLBs
Number of subjects: 57

Group type: COMPARATOR
Intervention: CBs
Number of subjects: 57
Study: 32687541

Group type: EXPERIMENTAL
Intervention: Vigorous physical activity
Number of subjects: 247

Group type: COMPARATOR
Intervention: Moderate or low physical activity
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Prolonged standing
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Squatting
Number of subjects: 247
Study: 34387827

Group type: EXPERIMENTAL
Intervention: Qishen Taohong Granule (QTG)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Trimethazidine (TMZ)
Number of subjects: 76
Study: 33899292

Group type: EXPERIMENTAL
Intervention: delta-tocotrienol (δT3) supplementation 250 mg once daily for 24 weeks
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo (cellulose soft gel capsule)
Number of subjects: 110
Study: 35832135

Group type: EXPERIMENTAL
Intervention: Preoperative planning (accurate unilateral puncture paths planned by preoperative CT data)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Conventional planning (multiple puncture procedures)
Number of subjects: 300
Study: 33903144

Group type: EXPERIMENTAL
Intervention: Quit Sense (usual care plus Quit Sense)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care (referral to the NHS SmokeFree website)
Number of subjects: 200
Study: 33276322

Group type: EXPERIMENTAL
Intervention: HD-tDCS
Number of subjects: 8

Group type: COMPARATOR
Intervention: SHAM
Number of subjects: 8
Study: 32237995

Group type: EXPERIMENTAL
Intervention: After-school physical activity club 3 d/wk
Number of subjects: 1194

Group type: EXPERIMENTAL
Intervention: After-school physical activity club 1 d/wk
Number of subjects: 1194

Group type: EXPERIMENTAL
Intervention: After-school physical activity club 2 d/wk
Number of subjects: 1194

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1194
Study: 33381204

Group type: EXPERIMENTAL
Intervention: Manipulative acupuncture (acupoints acupuncture combined with manipulations of twirling, lifting, and thrusting treatments)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Simple acupuncture (acupoints acupuncture therapy alone)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Manipulative acupuncture
Number of subjects: 120

Group type: COMPARATOR
Intervention: Simple acupuncture
Number of subjects: 120
Study: 35452377

Group type: COMPARATOR
Intervention: Didactic intervention
Number of subjects: 117

Group type: COMPARATOR
Intervention: Perspective-taking intervention
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 117
Study: 33495217

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP)
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Artesunate-mefloquine (ASMQ)
Number of subjects: 277

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL+)
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 277
Study: 35180154

Group type: EXPERIMENTAL
Intervention: Test set (OCT scan moved inferotemporally)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control set (no manipulation)
Number of subjects: 84
Study: 34764687

Group type: EXPERIMENTAL
Intervention: TLIP block with general anesthesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (general anesthesia alone)
Number of subjects: 60
Study: 35250820

Group type: EXPERIMENTAL
Intervention: Robot-assisted neurorehabilitation using ARAMIS
Number of subjects: 118

Group type: COMPARATOR
Intervention: Conventional neurorehabilitation
Number of subjects: 118
Study: 34187737

Group type: EXPERIMENTAL
Intervention: Percutaneous lumbar transfacet screw placement with the Facet-Link ® system
Number of subjects: 46

Group type: COMPARATOR
Intervention: Intraoperative complication
Number of subjects: 46

Group type: COMPARATOR
Intervention: Postoperative radiographic pseudarthrosis
Number of subjects: 46

Group type: COMPARATOR
Intervention: Additional surgery
Number of subjects: 46
Study: 34071868

Group type: EXPERIMENTAL
Intervention: Multi-ingredient pre-workout supplement (MIPS)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 11
Study: 34615636

Group type: EXPERIMENTAL
Intervention: Obinutuzumab 1000 mg
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 33308975

Group type: EXPERIMENTAL
Intervention: Financial incentives ($1.50 for each day the goal was met, with a 20% chance of a $100 reward if the goal was met on >75% of the first 30 postoperative days)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Financial incentives
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no financial incentives)
Number of subjects: 33
Study: 35928498

Group type: EXPERIMENTAL
Intervention: Diet group (DG)
Number of subjects: 1125

Group type: EXPERIMENTAL
Intervention: Physical Activity plus Diet group (PADG)
Number of subjects: 1125

Group type: COMPARATOR
Intervention: Physical Activity group (PAG)
Number of subjects: 1125

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 1125
Study: 35672832

Group type: EXPERIMENTAL
Intervention: E-HELD intervention (therapist-guided Internet-based cognitive-behavioral therapy)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: E-HELD intervention
Number of subjects: 130
Study: 32152326

Group type: EXPERIMENTAL
Intervention: T1 (2.5 g/L foliar application twice at nursery with a one‐week interval)
Number of subjects: 0

Group type: COMPARATOR
Intervention: T0 (control)
Number of subjects: 0
Study: 32646228

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 34
Study: 35798020

Group type: EXPERIMENTAL
Intervention: 50 g prunes
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: 100 g prunes
Number of subjects: 235

Group type: COMPARATOR
Intervention: Control
Number of subjects: 235
Study: 34173295

Group type: EXPERIMENTAL
Intervention: Ramsay scale
Number of subjects: 65
Study: 32748463

Group type: EXPERIMENTAL
Intervention: EBUS-TBNA
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: EUS-B-FNA
Number of subjects: 100
Study: 35729217

Group type: EXPERIMENTAL
Intervention: More time spent in clinical hypoglycemia (defined by median split)
Number of subjects: 211
Study: 33739437

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (12 weeks, twice weekly)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (continuation of usual lifestyle)
Number of subjects: 28
Study: 36470964

Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 33479274

Group type: EXPERIMENTAL
Intervention: Antibiotics administered in the first 48 hours after birth
Number of subjects: 91

Group type: COMPARATOR
Intervention: No antibiotics administered in the first 48 hours after birth
Number of subjects: 91
Study: 35055842

Group type: EXPERIMENTAL
Intervention: School-based behavior change intervention
Number of subjects: 20
Study: 32014355

Group type: EXPERIMENTAL
Intervention: Peer benchmarking intervention tool
Number of subjects: 13
Study: 32006180

Group type: EXPERIMENTAL
Intervention: Participation in an online support group via a closed Facebook group.
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Engagement in discussions on disease experiences, medications, social lives, online resources on RA, frustrations, messages of encouragement, and satirical depictions of their disease experience.
Number of subjects: 90
Study: 35294706

Group type: EXPERIMENTAL
Intervention: Housing Authority A vouchers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Housing Authority B vouchers
Number of subjects: 0
Study: 33098483

Group type: EXPERIMENTAL
Intervention: Healthy Choices intervention
Number of subjects: 183
Study: 32216471

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 1592

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 1592
Study: 35567778

Group type: EXPERIMENTAL
Intervention: Early autologous hematopoietic cell transplantation (AHCT) with post‐transplant maintenance therapy
Number of subjects: 758

Group type: EXPERIMENTAL
Intervention: Early autologous hematopoietic cell transplantation (AHCT)
Number of subjects: 758

Group type: COMPARATOR
Intervention: Low symptom burden at baseline
Number of subjects: 758

Group type: COMPARATOR
Intervention: Older age
Number of subjects: 758

Group type: COMPARATOR
Intervention: Employment status
Number of subjects: 758
Study: 34390604

Group type: EXPERIMENTAL
Intervention: Enriched RS2 cookies (16 g d-1 of Hi-Maize 260, Ingredion) for 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo cookies made with manioc flour
Number of subjects: 0
Study: 32614262

Group type: EXPERIMENTAL
Intervention: Lithium (n=30)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Quetiapine (n=49)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Healthy group (n=57)
Number of subjects: 79
Study: 36259883

Group type: EXPERIMENTAL
Intervention: ARM-SAD
Number of subjects: 130

Group type: COMPARATOR
Intervention: Standard AD
Number of subjects: 130
Study: 34178124

Group type: EXPERIMENTAL
Intervention: 25 mg intramuscular neridronate given once daily for 16 consecutive days
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 78
Study: 32728536

Group type: EXPERIMENTAL
Intervention: Lifestyle Modification with calorie deficit diet and strength training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lifestyle Modification
Number of subjects: 40
Study: 36269974

Group type: EXPERIMENTAL
Intervention: Randomized mirror circuits for benchmarking
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Randomized mirror circuits
Number of subjects: 16
Study: 34541720

Group type: EXPERIMENTAL
Intervention: nano-curcumin
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study: 36054285

Group type: EXPERIMENTAL
Intervention: Customized allogeneic bone block (CABB)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Autogenous bone block (ABB)
Number of subjects: 24
Study: 33016193

Group type: EXPERIMENTAL
Intervention: Balanced crystalloids
Number of subjects: 15802

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 15802
Study: 35192659

Group type: EXPERIMENTAL
Intervention: Video mode
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Audio mode
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Email mode
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Instant chat mode
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Survey mode
Number of subjects: 154

Group type: COMPARATOR
Intervention: Overall comparison across modes
Number of subjects: 154
Study: 33246494

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT), 30–40 treatment sessions in a high pressure chamber (2.4 atmospheres absolute) inhaling 100% oxygen through a mask.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 120
Study: 35279355

Group type: EXPERIMENTAL
Intervention: Homemade gelatin model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Homemade tofu model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercial model (US training block model)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Human tissue
Number of subjects: 0
Study: 32043986

Group type: EXPERIMENTAL
Intervention: Dexamethasone (20 mg IV once daily from day 1 to day 5, then 10 mg IV once daily from day 6 to day 10)
Number of subjects: 277

Group type: COMPARATOR
Intervention: Control group (continued routine intensive care)
Number of subjects: 277
Study: 36262517

Group type: EXPERIMENTAL
Intervention: TC-325
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control (best clinical management)
Number of subjects: 59
Study: 33971353

Group type: EXPERIMENTAL
Intervention: Brolucizumab (3 or 6 mg)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Brolucizumab therapy continued after first IOI-related AE
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Brolucizumab therapy not continued after first IOI-related AE
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Brolucizumab injections before first IOI-related AE
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Time to first IOI-related AE
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Best-corrected visual acuity (BCVA) change
Number of subjects: 49
Study: 32408979

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 1434
Study: 35031632

Group type: EXPERIMENTAL
Intervention: Balloon extracranial venoplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham extracranial venoplasty
Number of subjects: 0
Study: 34151855

Group type: EXPERIMENTAL
Intervention: Algorithm-guided DBS-settings
Number of subjects: 23

Group type: COMPARATOR
Intervention: Standard-of-care DBS-settings
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Latest version of algorithm-guided DBS-settings
Number of subjects: 23
Study: 32697879

Group type: EXPERIMENTAL
Intervention: Real tDCS
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 32
Study: 33144085

Group type: EXPERIMENTAL
Intervention: Atrial fibrillation (AF)
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: Excessive supraventricular ectopic activity (ESVEA)
Number of subjects: 850

Group type: COMPARATOR
Intervention: Implantable cardioverter defibrillator (ICD) implantation
Number of subjects: 850
Study: 35325834

Group type: EXPERIMENTAL
Intervention: High protein diet (22% CP)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Low crude fiber diet (30 g/kg CF)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Increasing crude fiber levels (from 3% to 7%)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Diet of 18% CP paired with 5% CF
Number of subjects: 9
Study: 34484379

Group type: EXPERIMENTAL
Intervention: Combination therapy of hydrocortisone (50 mg/6 h, intravenously), Vitamin C (1.5 g/6 h in 100 ml normal saline or DW5%, intravenously), and thiamine (200 mg/12 h in 50 ml normal saline or DW5%, intravenously)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Combination therapy of hydrocortisone, thiamine, and Vitamin C
Number of subjects: 58
Study: 33303119

Group type: EXPERIMENTAL
Intervention: TMVr plus guideline-directed medical therapy (GDMT)
Number of subjects: 614

Group type: COMPARATOR
Intervention: GDMT alone
Number of subjects: 614
Study: 36335573

Group type: EXPERIMENTAL
Intervention: benzoate 1000 (500 mg/day for the first 4 weeks, 1000 mg/day from the 5th week)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: benzoate 500 (fixed 500 mg/day)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: benzoate 750 (500 mg/day for the first 4 weeks, 750 mg/day from the 5th week)
Number of subjects: 149

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 149
Study: 35320441

Group type: EXPERIMENTAL
Intervention: Invention and problem-solve learning (PS-I)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mastery Learning (ML)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Instruction then practice (CON)
Number of subjects: 0
Study: 32556619

Group type: EXPERIMENTAL
Intervention: Patient-specific titanium onlay implant
Number of subjects: 10

Group type: COMPARATOR
Intervention: Autogenous inlay grafting technique
Number of subjects: 10
Study: 35870944

Group type: EXPERIMENTAL
Intervention: group-based parenting intervention for mothers with BPD
Number of subjects: 178

Group type: COMPARATOR
Intervention: waiting control group
Number of subjects: 178
Study: 33771557

Group type: EXPERIMENTAL
Intervention: 1 pass, 3 actuations (1:3)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 1 pass, 1 actuation (1:1)
Number of subjects: 40
Study: 32286322

Group type: EXPERIMENTAL
Intervention: Carbowhite (siliceous enterosorbent)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study: 34760143

Group type: EXPERIMENTAL
Intervention: Chewing gum as psychological intervention
Number of subjects: 89

Group type: COMPARATOR
Intervention: No intervention (Control group)
Number of subjects: 89
Study: 33308812

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Plyometric Training (PT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 34
Study: 34903325

Group type: EXPERIMENTAL
Intervention: ACCORd intervention (structured training for GPs on LARC counselling and access to rapid referral to insertion clinics)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACCORd intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACCORd intervention without start-up cost
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 0
Study: 32658498

Group type: EXPERIMENTAL
Intervention: Mailouts plus telephone support
Number of subjects: 588

Group type: COMPARATOR
Intervention: Mailouts alone
Number of subjects: 588

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 588
Study: 36091513

Group type: EXPERIMENTAL
Intervention: Health Weight Clinic PWMI
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Modified-Healthy Weight and Your Child PWMI
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness of PWMI
Number of subjects: 26
Study: 32317617

Group type: EXPERIMENTAL
Intervention: Everolimus with Reduced Calcineurin Inhibitor Exposure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34751177

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided percutaneous Achilles tenotomy (PAT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Percutaneous Achilles tenotomy (PAT) without image guidance
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (ultrasound-guided and control)
Number of subjects: 50
Study: 33600928

Group type: EXPERIMENTAL
Intervention: Drug-coated balloons (DCBs)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Uncoated balloon (UCB)
Number of subjects: 200
Study: 35128871

Group type: EXPERIMENTAL
Intervention: Deep embedding group
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Shallow embedding group
Number of subjects: 92

Group type: COMPARATOR
Intervention: Sham-embedding group
Number of subjects: 92
Study: 32271055

Group type: EXPERIMENTAL
Intervention: Compassionate mind training (CMT)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Relaxation music
Number of subjects: 73
Study: 34971525

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg i.v. infusion over 40 min)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Ketamine (10 mg/kg i.p.)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: (2R,6R)‐HNK (10 mg/kg i.p.)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Orchidectomy
Number of subjects: 57

Group type: COMPARATOR
Intervention: Ovariectomy
Number of subjects: 57
Study: 33063096

Group type: EXPERIMENTAL
Intervention: Nurse-led self-management and self-assessment program including educational video and home-based exercises, with monthly reporting of ASDAS/BASDAI scores.
Number of subjects: 502

Group type: COMPARATOR
Intervention: Comorbidities assessment (control group).
Number of subjects: 502